Product Program year 2020 Source: CMS Open Payments

Tas-102

Drug Oncology

Open in the dashboard

General payments

$87,844

78 payments

Research payments

$1,221,420

91 payments

Through program year 2020, $87,844 in general payments and $1,221,420 in research payments were reported against Tas-102 (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $48,925 24
2020 Research $591,080 16
2019 General $38,919 54
2019 Research $630,340 75

Breakdown

Who paid General payments · program years 2019–2020
  1. Taiho Oncology, Inc. $87,844 78 payments
Top recipients General payments · program year 2020
  1. Michael Savona Hematology · Nashville, TN $5,000 10% · 2 payments
  2. Namrata Vijayvergia Medical Oncology · Philadelphia, PA $5,000 10% · 2 payments
  3. Nilofer Azad Medical Oncology · Baltimore, MD $4,000 8% · 2 payments
  4. Elizabeth Griffiths Hematology & Oncology · Buffalo, NY $4,000 8% · 2 payments
  5. Jaroslaw MacIejewski Hematology · Cleveland, OH $4,000 8% · 2 payments

The top 5 of 16 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $25,600 52% · 9 practitioners
  2. Medical Oncology Internal Medicine $14,325 29% · 5 practitioners
  3. Hematology Internal Medicine $9,000 18% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. California $5,575 11% · 2 recipients
  2. Tennessee $5,000 10% · 1 recipient
  3. Pennsylvania $5,000 10% · 1 recipient
  4. Ohio $4,000 8% · 1 recipient
  5. Maryland $4,000 8% · 1 recipient

The top 5 of 15 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

78 general · 91 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record